We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+4.29%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$20.7B
AUM Growth
-$166M
Cap. Flow
-$582M
Cap. Flow %
-2.82%
Top 10 Hldgs %
30.44%
Holding
2,896
New
52
Increased
415
Reduced
1,909
Closed
89

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$65.1M
2
AAPL icon
Apple
AAPL
+$58M
3
MSFT icon
Microsoft
MSFT
+$49.2M
4
EFA icon
iShares MSCI EAFE ETF
EFA
+$25.9M
5
AL
Air Lease Corp
AL
+$21.6M

Sector Composition

Rank Sector Weight
1 Technology 30.28%
2 Financials 13.29%
3 Healthcare 10.43%
4 Consumer Discretionary 10.39%
5 Industrials 9.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SHC icon
1126
Sotera Health
SHC
$5.43B
$1.8M 0.01%
102,240
+10,954
+12% +$181K
MARA icon
1127
Marathon Digital Holdings
MARA
$3.56B
$1.8M 0.01%
200,619
-15,591
-7% -$230K
MIRM icon
1128
Mirum Pharmaceuticals
MIRM
$6.02B
$1.8M 0.01%
22,739
-735
-3% -$52.8K
GEF icon
1129
Greif
GEF
$5.03B
$1.8M 0.01%
26,525
-1,326
-5% -$83K
MGM icon
1130
MGM Resorts International
MGM
$11.1B
$1.79M 0.01%
49,168
-1,493
-3% -$50.7K
FBP icon
1131
First Bancorp
FBP
$4.49B
$1.79M 0.01%
86,310
-9,951
-10% -$205K
AIR icon
1132
AAR Corp
AIR
$5.77B
$1.79M 0.01%
21,576
+335
+2% +$27.7K
SHAK icon
1133
Shake Shack
SHAK
$2.98B
$1.78M 0.01%
21,870
-862
-4% -$76K
TARS icon
1134
Tarsus Pharmaceuticals
TARS
$3.02B
$1.77M 0.01%
21,674
-1,421
-6% -$106K
NMIH icon
1135
NMI Holdings
NMIH
$3.42B
$1.77M 0.01%
43,458
-2,852
-6% -$108K
OPLN
1136
Openlane
OPLN
$4.33B
$1.77M 0.01%
59,481
-2,009
-3% -$54.3K
CELC icon
1137
Celcuity
CELC
$4.22B
$1.77M 0.01%
17,734
+693
+4% +$57K
PSMT icon
1138
Pricesmart
PSMT
$5.55B
$1.76M 0.01%
14,381
-432
-3% -$52.7K
KGS icon
1139
Kodiak Gas Services
KGS
$6.3B
$1.76M 0.01%
47,161
+8,264
+21% +$292K
CATY icon
1140
Cathay General Bancorp
CATY
$4.31B
$1.76M 0.01%
36,414
-2,776
-7% -$133K
BEN icon
1141
Franklin Resources
BEN
$17.2B
$1.76M 0.01%
73,620
-2,397
-3% -$55K
AVA icon
1142
Avista
AVA
$3.24B
$1.76M 0.01%
45,605
-2,343
-5% -$91.5K
CARG icon
1143
CarGurus
CARG
$3.38B
$1.76M 0.01%
45,800
-2,356
-5% -$84.9K
AZZ icon
1144
AZZ Inc
AZZ
$4.52B
$1.75M 0.01%
16,363
-1,157
-7% -$120K
ARQT icon
1145
Arcutis Biotherapeutics
ARQT
$3.25B
$1.75M 0.01%
60,298
-4,187
-6% -$107K
BGC icon
1146
BGC Group
BGC
$5.2B
$1.75M 0.01%
196,051
-12,390
-6% -$112K
CALX icon
1147
Calix
CALX
$2.51B
$1.75M 0.01%
32,976
-1,255
-4% -$73.1K
NVST icon
1148
Envista
NVST
$4.51B
$1.74M 0.01%
80,317
-5,125
-6% -$105K
TVTX icon
1149
Travere Therapeutics
TVTX
$5.79B
$1.74M 0.01%
45,487
-7,091
-13% -$231K
TEAM icon
1150
Atlassian
TEAM
$42.1B
$1.74M 0.01%
10,711
+349
+3% +$54.8K

Similar funds

MetLife Investment Management's Q4 2025 Portfolio in Review

As of Q4 2025, MetLife Investment Management held 2,896 positions worth $20.7B, down 0.8% from $20.8B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Trading was light in Q4 2025: portfolio turnover was 4.9%. MetLife Investment Management opened 52 new positions and exited 89, leaving the 2,896-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 31% a quarter earlier, followed by Financials and Healthcare.

  • MetLife Investment Management's largest Q4 2025 buy was RTX Corp: 321,368 shares worth $58.9M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q4 2025, an estimated $54.6M increase.
  • MetLife Investment Management's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $65.1M.
  • MetLife Investment Management fully exited Kellanova in Q4 2025, selling an estimated $5.48M.
  • MetLife Investment Management's ten largest holdings make up 30% of its $20.7B portfolio in Q4 2025.
  • MetLife Investment Management opened 52 new positions and closed 89 in Q4 2025.
  • MetLife Investment Management's portfolio value fell 0.8% quarter-over-quarter to $20.7B.

Based on MetLife Investment Management's 13F filing for Q4 2025, filed 12 Feb 2026.